
Cegava 1000mg/500mg Injection
Marketer
Biocon
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Cegava 1000mg/500mg Injection
Combiflox 1000 mg/500 mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be solely under a physician's guidance. Adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are vital for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Cegava 1000mg/500mg Injection
Managing bacterial infections
Major Benefits of Cegava 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cegava 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Cegava 1000mg/500mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Cegava 1000mg/500mg Injection works:
Cegava Injection, containing 1000 mg Cefoperazone and 500 mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Cefoperazone's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counter bacterial resistance mechanisms, thereby boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cegava 1000 mg/500 mg Injection and alcohol can lead to adverse effects including facial flushing, tachycardia, nausea, increased thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Cegava, 1000 mg/500 mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, corresponding data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Cegava 1000 mg/500 mg Injection is considered safe while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Cegava 1000 mg/500 mg Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cegava 1000 mg/500 mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cegava 1000 mg/500 mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Cegava 1000mg/500mg Injection :
Omitting a scheduled dose of Cegava 1000 mg/500 mg Injection necessitates contacting your physician.
Facts to Know About Cegava 1000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
